Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Momentum Rank : 0 (As of May. 17, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition Momentum Rank?

Oracle Healthcare Acquisition has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Oracle Healthcare Acquisition Momentum Rank Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Executives

Andrew M Weiss	10 percent owner	222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc.	10 percent owner	500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc	10 percent owner	51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman	10 percent owner	7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c.	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg	director	C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg	director, 10 percent owner	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson	director	12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik	officer: CFO & Secretary
Joel D Liffman	director, officer: President and COO	C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines